TY  - JOUR
AU  - González Gascón y Marín, Isabel
AU  - Muñoz Novas, Carolina
AU  - Rodríguez Vicente, Ana-Eugenia
AU  - Quijada Álamo, Miguel
AU  - Hernández Sánchez, María
AU  - Pérez Carretero, Claudia
AU  - Ramos Ascanio, Victoria
AU  - Hernández Rivas, José Ángel
PY  - 2021
DO  - 10.3390/cancers13081782
SN  - 2072-6694
UR  - https://hdl.handle.net/20.500.14352/6887
T2  - Cancers
AB  - hronic lymphocytic leukemia (CLL) is an extremely heterogeneous disease. With the advent of oral targeted agents (Tas) the treatment of CLL has undergone a revolution, which has been accompanied by an improvement in patient’s survival and quality of...
LA  - eng
M2  - 1782
PB  - MPDI
KW  - chronic lymphocytic leukemia
KW  - prognosis
KW  - targeted therapy
TI  - From Biomarkers to Models in the Changing Landscape of Chronic Lymphocytic Leukemia: Evolve or Become Extinct
TY  - journal article
VL  - 13
ER  -